Crossref
Myelitis After Immune Checkpoint Inhibition: When Rare Presentations Demand a Broader Differential Diagnosis
Clinical and Experimental Neuroimmunology · 2026-11 · 17 (4)
DOI: 10.1111/cen3.70092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Neuroimmunology, online erschienen am 02.11.2026. Verfasst von Christian Messina und 1 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Messina, C., & Botta, A. (2026). Myelitis After Immune Checkpoint Inhibition: When Rare Presentations Demand a Broader Differential Diagnosis. Clinical and Experimental Neuroimmunology, 17(4). https://doi.org/10.1111/cen3.70092
Vancouver
Messina C, Botta A. Myelitis After Immune Checkpoint Inhibition: When Rare Presentations Demand a Broader Differential Diagnosis. Clinical and Experimental Neuroimmunology. 2026;17(4). doi:10.1111/cen3.70092
BibTeX
@article{Messina2026,
author = {Messina, Christian and Botta, Annarita},
title = {Myelitis After Immune Checkpoint Inhibition: When Rare Presentations Demand a Broader Differential Diagnosis},
journal = {Clinical and Experimental Neuroimmunology},
year = {2026},
volume = {17},
number = {4},
doi = {10.1111/cen3.70092}
}
EUVIMED